Mitogen-activated protein kinases and transcriptional responses in renal injury and repair

Current Opinion in Nephrology and Hypertension

Volumn 7, Issue 4, 1998, Pages 425-433

  Bonventre, Joseph V ^a   Force, Thomas ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P30; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ANALYSIS; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY DISEASE; PRENYLATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; HUMANS; KIDNEY; KIDNEY FAILURE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0031826209     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199807000-00013     Document Type: Review

References (89)

1. Ray BL, Sturgill TW. Insulin-stimulated microtubule-associated protein kinase is phosphorylated on tyrosine and threonine in vivo. Proc Natl Acad Sci USA 1988; 85:3753-3757.
2. Denhardt DT. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem. J 1996; 318:729-747.
3. Scrimgeour AG, Blakesley VA, Stannard BS, LeRoith D. Mitogenactivated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis. Endocrinology 1997; 138:2552-2558.
4. Liao D-F, Monia B, Dean N, Berk BC. Protein kinase C-z mediates • angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Biol Chem 1997; 272:6146-6150. In response to angiotensin II, PKC-z associates with Ras in vascular smooth muscle cells. Antisense PKC-z oligonucleotide treatment resulted in depletion of PKC-z protein and concentration-dependent decreases in angiotensin II-dependent ERK1/2 activation. By contrast, inhibition of PKC-z expression had no effect on phorbol ester or platelet derived growth factor-induced activation of ERK1/2.
5. Kyriakis JM, Force TL, Rapp UR, Bonventre JV, Avruch J. Mitogen regulation of c-Raf-1 protein kinase activity toward mitogen-activated protein kinase kinase. J Biol Chem 1993; 268:16009-16019.
6. Wang Y, Simonson MS, Pouyssegur J, Dunn MJ. Endothelin rapidly stimulates mitogen-activated protein kinase activity in rat mesangial cells. Biochem J 1992; 287:589-594.
7. Wang Y, Rose PM, Webb ML, Dunn MJ. Endothelin stimulates mitogen-activated protein kinase cascade through either ETA or ETB. Am J Physiol 1994; 267:C1130-1135.
8. 2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase. J Biol Chem 1994; 269:5693-5698.
9. q-protein-coupled pathway. J Biol Chem 1995; 270:8984-8990.
10. Muthalif MM, Benter IF, Uddin MR, Malik KU. Calcium/calmodulin-dependent protein kinase IIa mediates activation of mitogen-activated protein kinase and cytosolic phospholipase A2 in norepinephrine-induced arachidonic acid release in rabbit aortic smooth muscle cells. J Biol Chem 1996; 271:30149-30157.
11. Wan Y, Kurosaki T, Huang X. Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors. Nature 1996; 380:541-544.
12. Heldin C-H. Dimerization of cell surface receptors in signal transduction. Cell 1995; 80:213-223.
13. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990, 61:203-212.
14. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 1993: 363:45-51.
15. ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 1993; 364:308-313.
16. Liu D, Bienkowska J, Petosa C, Collier RJ, Fu H, Liddington R. Crystal structure of the zeta isoform of the 14-3-3 protein. Nature 1995: 376:191-194.
17. Xiao B, Smerdon SJ, Jones DH, Dodson GG, Soneji Y, Aitken A, Gamblin •• SJ. Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature 1995; 376:188-191. The crystal structure of the human T-cell 14-3-3 tau dimer is presented to 2.6 Å resolution. The dimer creates a large negatively charged channel at the base of which is a 16-residue segment that has been implicated in the binding of 14-3-3 to protein kinase C.
18. Luo Z, Tzivion G, Belshaw PJ, Vavvas D, Marshall M, Avruch J. Oligomer•• ization activates c-Rat-1 through Ras dependent mechanism. Nature 1996; 383:181-185. The authors fused sequences encoding the FK506-binding protein FKBP12 to c-Raf-1. By transfecting this into COS cells, and adding a dimeric FK506 derivative, Raf activity was increased to levels one-half that seen with epidermal growth factor. Thus oligomerization of Raf promotes Raf activation through a Ras-dependent mechanism.
19. Farrar MA, IIa-Alberola J, Perlmutter RM. Activation of the Raf-1-kinase cascade by coumermycin-induced dimerization. Nature 1996; 383:178-181.
20. q11 mediates the α1B adrenergic receptor-coupled activation of the ERK1/2 cascade. Activation from both receptors is blocked with inhibitors of calmodulin or overexpression of a dominant negative construct of the tyrosine protein kinase, Pyk. Signalling pathways for activation of the ERK cascade by the two different adrenergic receptors are presented.
21. Hawes BE, van Biesen T, Koch WJ, Luttrell LM, Lefkowitz RJ. Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation. J Biol Chem 1995; 270;17148-17153.
22. Nemenoff RA, Winitz S, Qian N-X, Van Putten V. Johnson GL, Heasley LE. Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J Biol Chem 1993; 268:1960-1964.
23. Lin L-L, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell 1993; 72:269-278.
24. Sturgill TW, Ray LB, Erikson E, Maller JL. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 1988; 334:715-718.
25. rsk isoform with a unique N-terminal sequence: growth factor stimulated kinase function and nuclear translocation. Mol Cell Biol 1995; 15:4353-4363.
26. Fukunaga R, Hunter T. Mnk1. a new MAP kinase-activated protein kinase. • isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J 1997; 16:1221-1933. The authors screened a HeLa cell cDNA library for MAP kinase substrates and identified Mnk1, which is a protein kinase which is phosphorylated and activated by ERK1 and p38 but not by SAPK/JNK.
27. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. Mitogen-activated protein • kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J 1997; 16:1909-1920. The authors define a new subfamily of protein kinases, Mnk1 and Mnk2, which bind to ERK1/2. Mnk1 but not Mnk2 also binds to p38. In vitro Mnk1 phosphorylates eukaryotic initiation factor-4E (elF-4E), at the physiologically relevant site, Ser 209.
28. Li Z, Bing OH, Long X, Robinson KG, Lakatta EG. Increased cardiomyocte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol 1997; 272:H2313-H2319,
29. Minich WB, Balasta ML, Goss DJ, Rhoads RE. Chromatographic resolution of in vivo phosphorylated and nonphosphorylated eukaryotic translation initiation factor elF-4E. Proc Natl Acad Sci USA 1994; 91:7668-7672.
30. Lenormand P, Sardet C, Pages G, L'Allemain G, Brunet A, Pouyssegur J. Growth factors induce nuclear translocation of MAP kinases (p42 and p44) but not of their activator MAP kinase kinase (p45) in fibroblasts. J Cell Biol 1993; 122:1079-1088.
31. Gonzalez F, Seth A, Raden D, Bowman D, Fay F, Davis R. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J Cell Biol 1993; 122:1089-1101.
32. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995; 9:726-735.
33. Treisman R. Regulation of transcription by MAP kinase cascades. Curr • Opin Cell Biol 1996; 8:205-215. Excellent review of the role of MAP kinase cascades in transcriptional regulation.
34. Treisman R. Journey to the surface of the cell: Fos regulation and the SRE. EMBO J 1995; 14:4905-4913.
35. TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 1992; 358:414-416.
36. Chen R-H, Sarnecki C, Blenis J. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol Cell Biol 1992; 12:915-927.
37. Xing J, Ginty DD, Greenberg ME. Coupling of the RAS-MAPK pathways to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 1996; 273:959-960.
38. Gupta S, Davis RJ. MAP kinase binds to the NH2-terminal activation domain of c-Myc. FEBS Lett 1994; 353:281-285.
39. Marshall C. Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80:179-185.
40. Pages G, Lenormand P, L'Allemain G, Chambard J-C, Meloche S, Pouyssegur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 1993; 90:8319-8323.
41. Stein-Oakley AN, Maguire JA, Dowling J, Perry G, Thomsom NM. Altered expression of fibrogenic growth factors in IgA nephropathy and focal and segmental glomerulonephritis. Kidney Int 1997; 51:195-204.
42. Terada Y, Yamada T, Nakashima O, Sasaki S, Nonoguchi H, Tomita K, Marumo F. Expression of PDGF and PDGF receptor mRNA in glomeruli in IgA nephropathy. J Am Soc Nephrol 1997; 8:817-819.
43. Wilmer WA, Tan LC, Dickerson JA, Danne M, Rovin BH. Interleukin-1β induction of mitogen-activated protein kinases in human mesangial cells role of oxidation. J Biol Chem 1997; 272:10877-10881.
44. Bruzzi I, Corna D, Zoja C, Orisio S, Schiffrin EL, Cavallotti D, Remuzzi G, Benigni A. Time course and localization of endothelin-1 gene expression in a model of renal disease progression. Am J Pathol 1997; 151:1241-1247.
45. ras activation at 30 min is not accompanied by an activation of ERK.
46. Bokemeyer D, Guglielmi KE, McGinty A, Sorokin A, Lianos EA, Dunn MJ. • Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats. J Clin Invest 1997; 100:582-588. The authors find an increase in glomerular MEK and ERK activities over prolonged periods of time in an accelerated model of anti-glomerular basement membrane glomerulonephritis in rats. In contrast, stress-activated protein kinase activities were activated only in the early stages of the disease.
47. Haneda M, Araki S, Togawa M, Sugimoto T, Isone M, Kikkawa R. Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 1997; 46:847-853.
48. Bonventre JV, Colvin R. Adhesion molecules in renal disease. Curr Opin Nephrol Hypertens 1996; 5:254-261.
49. Cybulsky AV, McTavish AJ: Extracellular matrix is required for MAP kinase activation and proliferatiion of rat glomerular epithelial cells. Biochem Biophys Res Comm 1997; 231:160-166.
50. Krishnamurti U, Rondeau E, Sraer J-D, Michael AF, Tsilibary EC. Alterations in human glomerular epithelial cells interacting with nonenzymatically glycosylated matrix. J Biol Chem 1997; 272:27966-27970.
51. Wijesekera DS, Zarama MJ, Paller MS. Effects of integrins on proliferation and apoptosis of renal epithelial cells after acute injury. Kidney Int 1997; 52:1511-1520.
52. Xu Q, Liu Y, Gorospe M, Udelsman R, Holbrook J. Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest 1996; 97:508-514.
53. Dubey RK, Zhang HY, Reddy SR, Boegehold MA, Kotchen TA. Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats. Am J Physiol 1993; 265:R726-R732.
54. Yoshioka S, Nishino H, Shiraki T, Ikeda K, Koike H, Okuno A, Wada M, Fujiwara T, Horikoshi H. Antihypertensive effects of C5-045 in treatment of obese Zucker rats. Metabolism 1993; 42:75-80.
55. Zhang H, Reddy S, Kotchen T. Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity. Hypertension 1994; 24:106-110.
56. Law RE, Meehan WP, Xi X-P, Graf K, Wuthrich DA, Coats W, Faxon D, Hsueh WA. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J Clin Invest 1996p; 98:1897-1905.
57. Graf K, Xi X-P, Hsueh WA, Law RE. Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells. FEBS Letf 1997, 400:119-121.
58. Kypta RM, Goldberg Y, Ulug ET, Courtneidge SA. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell 1990; 62:481-492.
59. Kyriakis JM, Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 1996; 271:24313-24316
60. Kyriakis JM, Avruch J. Protein kinase cascades activated by stress and •• inflammatory cytokines. BioEssays 1996; 18:567-577. Excellent review of protein kinase cascades that are activated by stress and inflammatory cytokines.
61. Kyriakis JM, Avruch J. pp54 microtubule-associated protein 2 kinase. J Biol Chem 1990; 265(October):17355-17363.
62. Kyriakis JM, Banerjee P. Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994; 369:156-160.
63. Force T, Bonventre JV. Growth factors and mitogen-activated protein • kinases. Hypertension 1998; 31: In press. A review of the role of growth factors in activation of the MAP kinase pathways with special emphasis on the role of these pathways in the cardiovascular system.
64. Zhang S, Han J, Sells MA, Chernoff J, Knaus UG, Ulevitch RJ, Bokoch GM, Rho family GTPases regulate p38 MAP kinase through the downstream mediator Pak1. J Biol Chem 1995; 270:23934-23936.
65. Pombo C, Kehrl J, Sanchez I, Katz P, Avruch J, Zon L, Woodgett J, Force T, Kyriakis J. Activation of the SAPK pathway by the human STE20 homolog germinal centre kinase. Nature 1995; 377:750-754.
66. Frost JA, Steen H, Shapiro P, Lewis T, Ahn N, Shaw PE, Cobb MH. Cross-• cascade activation of ERKs and ternary complex factors by Rho family proteins. EMBO J 1997; 16:6426-6438 The authors demonstrate that the Rho family of small molecular weight G proteins, such as Rac1 and Cdc42s, which activate the SAPK/JNKs, cooperate with Raf to activate the ERK pathway. This results in activation of the ternary complex and c-fos gene expression. Rho family members utilize PAKs for this synergy. PAK1 phosphorylates MEK1 at a site important for Raf-1 binding
67. Whitmarsh AJ, Yang S-H, Su M-S, Sharrocks AD, Davis RJ. Role of p38 •• and JNK mitogen-activated protein kinases in activation of ternary complex factors. Mol Cell Biol 1997; 17:2360-2371. Elk-1 and SAP-1 bind together with serum response factor to the serum response element in the c-fos promoter. In NIH 3T3 cells both SAPK/JNK and p38 MAP kinases are required for IL-1-induced stimulation of Elk-1 transcriptional activity, while only p38 MAP kinase contributes to IL-1 -stimulated SAP-1 activity. By contrast, in CHO cells SAPK/JNK, but not p38, is required for Elk-1 dependent gene activation and neither SAPK/JNK nor p38 is required for IL-1 signaling to SAP-1.
68. Morooka H, Bonventre JV, Pombo CM, Kyriakis JM, Force T. Ischemia and reperfusion enhance ATF-2 and c-Jun binding to cAMP response elements and to an AP-1 binding site from the c-jun promoter. J Biol Chem 1995; 270:30084-30092,
69. Read MA, Whitley MZ, Gupta S, Pierce JWB, J., Davis RJ, Collins T. • Tumor necrosis factor alpha-induced E-selectin expression is activated by the NFκB and c-Jun N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem 1997; 272:2753-2761. The authors demonstrate that a heterodimer of the transcription factors, ATF-2 and c-Jun is constitutively bound to the PDII domain of the E-selectin promoter in endothelial cells. Upon TNFα stimulation there is phosphorylation of both ATF-2 and c-Jun associated with stable contact with p38 and SAPK/JNK, respectively. This pathway of activation, together with MEKK1 dependent activation of NFκ-B, act together to result in maximal expression of E-selectin.
70. Wang XZ, Ron D. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP Kinase. Science 1996; 272:1347-1349.
71. Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ. Activation of the • transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 1997; 386:296-299. In monocytic cells, lipopolysaccharide increases the transactivation activity of myocyle-enhancer factor 2C (MEF2C) through p38-mediated phosphorylation. Increased MEF2C expression results in increased c-jun gene transcription.
72. Kato Y, Kravchenko VV, Tapping RI, Han J, Ulevitch RJ, Lee JD. • BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J 1997; 16:7054-7066. The authors report that myocyte-enhancer factor 2C (MEF2C) is phosphorylated and activated by big map kinase 1 (BMK1), also known as ERK5. Serum is a potent stimulus of BMK1-induced MEF2C phosphorylation.
73. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb M. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. Embo J 1996; 15:4629-4642.
74. Huot J, Houle F, Marceau F, Landry J. Oxidative stress-induced actin • reorganization mediated by the p38 mitogen-activated protein kinase/heat shock 27 pathway in vascular endothelial cells. Circ Res 1997; 80:383-392. In endothelial cell reactive oxygen species induce reorganization of F-actin via activation of p38, which resulted in activation of MAP kinase-activated protein kinase-2/3 and phosphorylation of the F-actin polymerization modulator, heat shock protein-27.
75. Guay J, Lambert H, Gingras-Breton G, Lavoie J, Huot J, Landry J. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci 1997; 110:357-368.
76. Saklatvala J, Rawlinson L, Waller RJ, Sarsfield S, Lee JC, Morion LF, Barnes MJ, Farndale HW. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem 1996; 271:6586-6589.
77. Kramer RM, Roberts EF, Um SL, Borsch-Haubold AG, Watson SP, Fisher MJ, Jakubowski JA. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 in thrombin-stimulated platelets. J Biol Chem 1996; 271:27723-27729.
78. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270:1326-1331.
79. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X. Cell 1996; 87:619-628.
80. Wang H-G, Rapp UR, Reed JC. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 1996; 87:629-638.
81. Bogoyevitch MA, Gillespie-Brown J, Ketlerman AJ, Fuller SJ, Ben-Levy R, Ashworth A, Marshall CJ, Sugden PH. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. Circ Res 1996; 79:162-173.
82. Araki S, Haneda M, Togawa M, Kikkawa R. Endothelin-1 activates c-Jun NH2-terminal kinase in mesangial cells. Kidney Int 1997; 51:631-639.
83. Molnar A, Theodoras AM, Zon LI, Kyriakis JM. Cdc42Hs, but not Rac1. inhibits serum-stimulated cell cycle pregression at G1/S through a mechanism requiring p38/RK. J Biol Chem 1997; 272:13229-13235.
84. Pombo CP, Bonventre JV, Avruch J, Woodgett JR, Kyriakis JM, Force T. The stress-activated protein kinases (SAPKs) are major c-Jun aminoterminal kinases activated by ischemia and reperfusion. J Biol Chem 1994; 269:26546-26551.
85. DiMari J, Megyesi J, Udvarhelyi N, Price P, Davis R, Safirstein R. N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol 1997; 272:F292-F298.
86. Wemer MH, Clore M, Fisher CL, Fisher RJ, Trinh L, Shiloach J, Gronenborn AM. The solution structure of the human ETS1-DNA complex reveals a novel mode of binding and true side chain intercalation. Cell 1995; 83:761-771.
87. Yin T, Sandhu G, Wolfgand CD, Burrier T, Webb RL. Rigel DF, Hai T, Whelan J. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem 1997; 272:19943-19950.
88. Pombo CM, Bonventre JV, Molnar A, Kyriakis J, Force T. Activation of a human Ste20-like kinase by oxidant stress defines a novel stress response pathway. EMBO J 1996; 15:4537-4546.
89. 2+]. J Biol Chem 1997; 272:29372-29379. A novel member of the Ste-20 family of protein kinases is identified. This kinase, SOK-1, is activated with chemical anoxia via an oxidant stress-related process that is both critically dependent on and amplified by an increase in cytosolic free calcium concentration.